Veterans at one health system were asked to rate the reasonableness of using age and risk calculators in decisions about screening cessation.
The guideline focuses on oral and topical 5-aminosalicylic acid medications, rectal corticosteroids, and oral budesonide in patients with mild to moderate disease.
Although hypnotherapy did not improve quality of life, psychological symptoms, cognition, self-efficacy, or irritable bowel syndrome (IBS) symptoms significantly more than an educational support program, it may provide relief to patients by changing their perception of IBS.
CT-P13 and infliximab were compared in infliximab-naive patients who had recently started treatment with either drug.
While the number of medical device reports associated with patient infections has declined by 62% since peaking in 2015, the FDA and duodenoscope manufacturers continue to address issues around device reprocessing.
Conference coverage in the December ACP Hospitalist addressed acute-on-chronic liver failure and inpatient constipation.
Proton-pump inhibitor cotherapy significantly reduced risk among patients on anticoagulation, a cohort study found.
In Barrett esophagus, high- vs low-dose esomeprazole improved clinical outcomes; aspirin vs no aspirin did not
The safety of high-dose proton-pump inhibitor therapy is probably acceptable, but the addition of aspirin carries more risk, has less evidence on efficacy, and needs an individualized approach, an ACP Journal Club commentary said.